JAK2 MUTATION, TNF-Α AND IL 6 PREDICT RESPONSE TO JAK INHIBITOR IN RHEUMATOID ARTHRITIS PATIENTS

被引：0
作者：
Hussein, Y. Adel Abdelsalam [1 ]
Sadeq, Y. [2 ]
机构：
[1] Mansoura Univ Hosp, Rheumatol, Mansoura, Egypt
[2] Mansoura Univ Hosp, Clin Pathol, Mansoura, Egypt
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Rheumatoid arthritis; Prognostic factors;
D O I：
10.1136/annrheumdis-2023-eular.840
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0358
引用
收藏
页码：429 / 430
页数：2
相关论文
共 3 条
  • [1] Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease
    Kontzias, Apostolos
    Kotlyar, Alexander
    Laurence, Arian
    Changelian, Paul
    O'Shea, John J.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2012, 12 (04) : 464 - 470
  • [2] Selective JAK inhibitors in development for rheumatoid arthritis
    Norman, Peter
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (08) : 1067 - 1077
  • [3] Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4
    Watford, WT
    Hissong, BD
    Bream, JH
    Kanno, Y
    Muul, L
    O'Shea, JJ
    [J]. IMMUNOLOGICAL REVIEWS, 2004, 202 : 139 - 156
1